Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by riverrrow


V.TLT

RE:RE:RE:RE:RE:PP COMING

I think 27 investors participated in the last pp.  It will be...

January 19, 2024

V.TLT

RE:RE:today's price action

Each successive pp seems to be priced lower and lower, so it would seem the...

January 19, 2024

V.TLT

TLT share price DOOM LOOP

We all know it's coming.  A pp financing.  Probably the same 10...

January 18, 2024

V.TLT

RE:RE:Multiple

My guess would be $118 million gross cost to patients, my guess after tax...

January 16, 2024

V.TLT

RE:Clinical Trials Arena

A paltry $118 million in sales in 2029 ?  Why are we even here and more...

January 16, 2024

C.BEE

Business dealings in South Africa

It's always nice when a new customer approaches you first.  "We...

January 16, 2024

V.TLT

RE:RE:RE:RE:Update on Phase II Bladder Cancer

Overpromise and under deliver.  That's the best strategy for any...

January 15, 2024

V.TLT

RE:RE:RE:RE:RE:RE:September 2023 Financing

It's shocking to think that TLT share price might not be trading above 35...

January 12, 2024

V.TLT

RE:September 2023 Financing

It's sooo easy to push the share price down, nearly impossible to bring...

January 10, 2024

V.TLT

RE:September 2023 Financing

They're taking a loss selling at 22 cents but they might be raising money...

January 10, 2024

V.TLT

RE:RE:RE:RE:RE:Dr. Ashish Kamat Interview - BOND-003 Study Results

Thanks for your posts everybody.  I forgot how some researchers present...

January 9, 2024

V.TLT

RE:RE:Dr. Ashish Kamat Interview - BOND-003 Study Results

Well, that's kind of depressing.  Another competitor for Ruvidar...

January 9, 2024

V.TLT

RE:RE:J & J Granted BTD for treatment of NMIBC using TAR-200

So what is the CR at 18 months?  Weren't posters arguing that's...

January 4, 2024

V.TLT

RE:When I first bought TLT over 10 years ago I thought

I agree 100%.  In theory the CR rate should be much much higher than 35%...

January 3, 2024

V.TLT

RE:RE:ImmunityBio Snags $320M Royalty Deal Ahead of FDA Decision

The most recently completed financing was about the most investor friendly...

January 3, 2024

V.TLT

RE:Email from Matthew Perraton

Must be a very new TLT employee writing these emails.   All of us...

January 2, 2024

V.TLT

RE:Big Breakthrough In Cancer Treatment: Scientists Destroy 99%

A test tube full of cancer cells doesn't tell you how many healthy cells...

December 28, 2023

V.VPT

RE:RE:RE:It's all coming together..

Yes, congrats to George for bringing this company  back to life and...

December 24, 2023

V.VPT

RE:“A game changer in cardiac care” VENTRIPOINT

What I like to see is how the clinician has expanded the use of  VMS...

December 24, 2023

T.CM

Up, Up, and Away !!!

Up more than 20% from it's recent lows in November.  Even I am in...

December 22, 2023